1. Home
  2. SPPL vs GOSS Comparison

SPPL vs GOSS Comparison

Compare SPPL & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPPL

SIMPPLE LTD.

HOLD

Current Price

$3.53

Market Cap

37.0M

Sector

N/A

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.16

Market Cap

41.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPPL
GOSS
Founded
2016
2015
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.0M
41.7M
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
SPPL
GOSS
Price
$3.53
$0.16
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$4.19
AVG Volume (30 Days)
1.8M
16.5M
Earning Date
04-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$48,471,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$201.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$0.14
52 Week High
$7.00
$3.87

Technical Indicators

Market Signals
Indicator
SPPL
GOSS
Relative Strength Index (RSI) 59.49 30.33
Support Level $3.49 $0.16
Resistance Level $4.60 $0.36
Average True Range (ATR) 0.31 0.02
MACD 0.01 0.00
Stochastic Oscillator 70.32 24.39

Price Performance

Historical Comparison
SPPL
GOSS

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software (Facilities management software). The majority of its revenue is generated from the Robots segment. The company has expanded its operations into Australia /New Zealand and may also enter or expand in other geographic markets such as Canada, Hong Kong, Japan, the Middle East, the United Kingdom, Europe and the United States.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Share on Social Networks: